Countdown 3 Days | 2024 Digital Therapeutics Conference Welcomes You to Explore Its Three Major Exhibition Zones!
The Time Is Ripe for the Development of Digital Health. Driven by digital technologies, the field of digital therapeutics is demonstrating unprecedented vitality and potential. A growing number of innovative enterprises are entering this sector, accelerating technological iteration and expanding application scenarios. From startups to industry giants, numerous companies are leveraging diverse collaborations and technological innovations to facilitate the rapid integration of digital therapeutics into clinical practice, thereby enhancing patient well-being.
The 2024 Digital Therapeutics Conference, hosted by Beijing Danhuang Technology Co., Ltd. (VB100, VCBeat, Eggshell Research Institute), organized by Chongqing Dongmaicheng Technology Co., Ltd. and Hainan Danhuang Technology Co., Ltd., and held in strategic partnership with Hainan Eco-Software Park Group Co., Ltd. and Beijing Shuimu Jinsheng Medical Technology Service Co., Ltd., will be held at the Hilton Haikou Meilan Hotel in Haikou, Hainan, on August 30–31, 2024.
Specially curated themed exhibition areas were featured during the event, including"Hainan – Exhibition of New Scenario Achievements in Global Digital Therapeutics Innovation Island"、“Digital Health Innovative Technology Products Debut Exhibition”and multiple otherInnovative Exhibitors.
To help attendees better understand exhibitor information and navigate the exhibition, we have organized the exhibition areas into curated collections. Those interested in the products, services, and business systems featured are welcome to visit the corresponding booths for discussions and negotiations!
(Exhibition Area Planning: Please refer to the on-site arrangement for the final version.)
In 2022, the General Office of the Hainan Provincial People's Government issued the "Several Measures for Accelerating the Development of the Digital Therapeutics Industry in Hainan Province," which is the first policy document nationwide and globally to provide support and safeguards for the entire lifecycle of digital therapeutics. In March 2024, the "Key Tasks for Deepening the Reform of the Medical and Healthcare System in Hainan Province in 2024" was released, explicitly promoting the application and popularization of smart health technology products, such as digital therapeutics, at the primary care level, with the aim of establishing Hainan as a highland for digital therapeutics innovation. In May 2024, the "Notice of the Hainan Provincial Health Commission on Launching the Application and Review Process for Hainan Provincial Digital Therapeutics Diagnosis and Treatment Centers" was issued. This initiative seeks to select qualified medical institutions to serve as Hainan Provincial Digital Therapeutics Diagnosis and Treatment Centers, gradually integrate digital therapeutics into routine disease diagnosis and treatment pathways, and accelerate the sustained and healthy development of the digital therapeutics sector.
Guided by various policies, Hainan has actively promoted the application of digital therapeutics (DTx) products, deeply expanded innovative application scenarios for DTx, and achieved fruitful results by launching pilot programs for DTx in diabetes management, cognitive rehabilitation for the elderly, and interventions for children aged 0–6 with autism spectrum disorder.
“Hainan—Exhibition of Achievements in New Scenarios for the Global Digital Therapeutics Innovation Island”, useScenario-basedin a manner that showcases Hainan's recent achievements inHospitals, Communities, and Homesinnovation and application of innovative digital therapeutics products in such scenarios. By accelerating the development of digital therapeutics and the digital transformation of healthcare, this initiative supports the modernization of Hainan’s healthcare system and the construction of a Healthy Hainan.
Hospital Scenario
Community Scenarios
Home Setting
12mm Health Technology (Hainan) Co., Ltd.
Product Name: Myopia Risk Factor Monitor
Product Introduction:
The three globally recognized pillars of myopia prevention and control—outdoor activities, orthokeratology lenses, and low-concentration atropine eye drops—have been widely adopted in clinical practice as treatment regimens for myopia. However, the most critical intervention, "outdoor activities," currently lacks quantitative guidelines and is only addressed through qualitative recommendations. Correspondingly, "insufficient outdoor activity" and "increased near-work visual demand" have emerged as two major risk factors for myopia. Establishing quantitative metrics for these two risk factors is equivalent to defining the quantitative parameters for "outdoor activities." The Myopia Risk Factor Monitor is a medical device that utilizes multiple sensors to acquire and record the visual environments and behaviors of children and adolescents aged 4 to 18 years who have myopia or insufficient hyperopic reserve, and provides alerts for risky visual behaviors.
Beijing Asou Aba Technology Co., Ltd.
Product Name: AI Individualized Training Robot
Product Introduction:
This product is a digital rehabilitation intervention system designed for children with autism spectrum disorder, global developmental delay, and intellectual developmental disorders. Grounded in evidence-based medicine and driven by software algorithms, the system leverages developmental milestones and principles of neuroplasticity, employing behavioral analysis intervention strategies to construct narrative scenarios. It provides quantitative, standardized, and interactive digital assessments and rehabilitation therapies for cognitive abilities, as well as social skills training. By integrating AI algorithms, extensive content resources, and situational simulation strategies, the system offers personalized, interactive, and multi-contextual therapeutic experiences. As a novel treatment model in the field of autism, it innovates upon the traditional “manual intervention” approach by establishing a new paradigm of “human + digital intervention + follow-up disease management.” This model reduces labor costs, overcomes spatial limitations in autism treatment, enhances intervention efficiency and outcomes, lowers rehabilitation expenses for families with autistic children, empowers rehabilitation institutions to expand capacity and improve efficiency, supplies governments with innovative products aligned with health economics, improves the cost-effectiveness of fiscal expenditures for disability rehabilitation assistance, and fills a domestic gap in this field.
Alambel Health Technology Group
Product Name: Alanbell Intestinal Barrier Function Test and Assessment
Product Introduction:
Alanbell’s Intestinal Barrier Function Test and Assessment is currently the exclusive testing service of its kind in China. Addressing the widespread functional gastrointestinal health risks among the Chinese population, this assessment incorporates four key indicators evaluating intestinal barrier integrity and gut microbiota. By precisely detecting specific markers of the intestinal epithelial mucosal barrier—such as Candida, zonulin, occludin, and lipopolysaccharides (LPS)—it sensitively identifies the integrity of the subject’s intestinal barrier. Based on the test results, targeted intervention recommendations are provided, aiming to achieve early detection and prevention of diseases, thereby offering a scientific basis for personalized medicine and health management.
Alambel Health Technology Group
Product Name: Alanbell Saiweiyi Algorithm
Product Introduction:
Alambel has innovatively developed the Alambel-Saiweiyi Algorithm System by building upon the Meiaote test items and the Saiweiyi algorithm, integrating vast amounts of domestic and international clinical data with AI technology. Grounded in the principles of evidence-based medicine, this system intelligently generates interpretation reports, risk assessments, and recommendations by incorporating users’ lifestyle habits, laboratory and diagnostic test results, medical consultations, monitoring data, and health management adherence. The outputs include analyses of abnormal indicators, disease risk profiles, health management guidance, and effectiveness evaluations, thereby truly achieving “quantifiable, visualizable, and manageable” disease risk assessment. The Alambel-Saiweiyi Algorithm System has been deployed across diagnostic and treatment institutions under the Alambel Health Management Group, covering 22 types of risk assessments and 28 chronic diseases. It assists physicians and health managers in promptly identifying risks associated with abnormal indicators, providing interpretations and health management recommendations, monitoring trends in these indicators, evaluating the effectiveness of health interventions, and enabling timely corrective actions.
Nanjing Institute of Digital Health Industry Technology, Chinese Academy of Sciences
Product Name: Smart Ring for Physical Blood Pressure Reduction
Product Introduction: The Physical Blood Pressure-Lowering Smart Ring is the world’s first device to precisely and quantitatively assess autonomic nervous system indicators—specifically Cardiorespiratory Resonance Amplitude (CRA) and Cardiorespiratory Resonance Factor (CRF). It provides targeted guided training for users with sympathetic overactivity or insufficient vagal tone, significantly reducing blood pressure elevation caused by autonomic dysfunction within three weeks.
Guangzhou Baishi Medical Technology Co., Ltd.
Product Name: Baishi Zeus Smart Image-Guided Precision Minimally Invasive Surgical Platform
Product Introduction: The “Zeus” Intelligent Minimally Invasive Surgical Platform, independently developed by Baishi Medical, comprises several subsystems: digital twin-based 3D reconstruction and segmentation, surgical planning, real-time multimodal fusion of imaging and optical holography, 3D visualization with real-time positioning and navigation, and digitally assisted instrument therapy. Guided by the core principles of “digitalization, precision, and standardization,” Baishi Zeus creates a new-generation innovative ecosystem for minimally invasive treatment. It empowers the minimally invasive therapy industry and various clinical minimally invasive specialties, enhances the efficiency and overall benefits of medical resource utilization, promotes equity and high quality in healthcare services, and makes surgical treatment more accessible, efficient, and safe!
Zhongyu Life (Shanghai) Medical Technology Development Co., Ltd.
Product Name: Smart Health Ring
Product Description: Smart Health Ring; Model: Hi-Pluse 20/Hi-Pluse 18; Charging: Magnetic USB charging port, input voltage DC 5V, input current <0.2A; Dimensions: Size L: horizontal diameter 20mm, vertical diameter adjustable from 16.76mm to 21.76mm; Size S: horizontal diameter 18mm, vertical diameter adjustable from 15.5mm to 20.5mm; Power Source: Internal lithium battery, 3.7V; Built-in Sensors: Accelerometer, three-wavelength photoplethysmography (PPG) sensor; Communication Interface: Bluetooth 4.1 BLE, operating frequency 2.4–2.4835GHz; Modulation Method: GFSK; Frequency Hopping; Adaptive Frequency Hopping; Transmit Power: 4dBm; Wavelengths: Red light 660±10nm, power ≤10mW; Infrared 940±20nm, power ≤10mW; Operating Time: Up to approximately 12 hours for continuous monitoring, standby time approximately 48 hours; Weight: Approximately 10g; Operating Environment: Temperature 5–40°C, relative humidity 30%–80%, atmospheric pressure range 70kPa–106kPa.
Shanghai Aikai Medical Technology Co., Ltd.
Product Name: AI-Regulated Implantable Neuromodulation Therapy Device
Product Introduction: AKNeuro-PNFS by Aikai Medical is a Percutaneous Neuro Field Stimulator (PNFS) system. It helps alleviate symptoms of acute and chronic neuropathic pain, treat drug addiction, and manage insomnia by stimulating the branches of cranial nerves V, VII, IX, and X at auricular neuro-acupoints, as well as other nerves identified through localization measurements.
Shanghai Shengzhe Medical Technology Co., Ltd.
Product Name: SA100 Integrated Ultrasonic and High-Frequency Surgical System
Product Introduction:
SA100 Ultrasonic and High-Frequency Integrated Surgical System is a new-generation intelligent, integrated surgical energy platform. The device and its consumable components integrate two distinct output energy modes: ultrasonic energy and high-frequency (electrosurgical) energy. The ultrasonic mode incorporates the latest-generation RTTE II intelligent algorithm, which adaptively adjusts ultrasonic energy output based on tissue type, thereby enhancing cutting and coagulation performance of the ultrasonic transducer. The ultrasonic transducer can routinely seal vessels up to 5 mm in diameter. The console features an Advanced Hemostasis Mode; when activated, pressing the MIN button on the ultrasonic transducer handle engages this mode, which provides superior hemostatic efficacy and can seal vessels up to 7 mm in diameter. The Advanced Bipolar Mode is a large-vessel sealing module capable of closing vessels up to 7 mm in diameter. Its precisely engineered jaw design addresses various types of intraoperative bleeding. Equipped with the new MPTS intelligent impedance feedback system, the device delivers appropriate high-frequency electrical energy in real time based on impedance feedback after the vessel is clamped and the activation button is pressed, automatically ceasing energy output upon successful vessel sealing. The jaws feature a physical blade-ejection mechanism that deploys the blade to cut vessels or tissue after sealing is complete. This product has been granted multiple patents, fills a domestic gap in this category of medical devices in China, and matches the performance of comparable international brands. It is suitable for a wide range of routine surgeries as well as procedures with moderate technical complexity.
Shanghai Huicheng Scientific and Educational Instruments Co., Ltd.
Product Name: Cognitive Impairment Sleep Mind-Body Digital Intelligence Management System
Product Introduction:
Cognitive disorders, such as the prevalent Alzheimer’s disease (AD), present numerous challenges, including difficulties in early diagnosis, complex diagnostic procedures, limited treatment options, and a lack of management tools. This system comprises wearable devices, mobile applications (user-facing and administrative interfaces), and a big data platform, creating a comprehensive digital management system for the entire course of cognitive disorders. Through daily monitoring via wearable devices, it tracks users’ sleep patterns, physical activity, heart rate variability, and other metrics in real time. By leveraging machine learning and artificial intelligence algorithms to analyze this data, the system establishes personalized assessments of physical and mental status. Combined with standardized scales, it enables early screening and longitudinal follow-up for cognitive disorders. For high-risk populations, the system provides personalized brainwave audio digital therapeutics. Using audio-based physical intervention technology, it stimulates and activates neuronal activity, accelerates the clearance of metabolic waste products such as beta-amyloid, and delays the decline of brain function. Furthermore, it safely and effectively helps users improve sleep, mood, and overall psychophysical well-being, thereby preventing or delaying the progression of cognitive disorders while enhancing patients’ quality of life and reducing caregiver burden. Concurrently, long-term data analysis facilitates follow-up tracking of key populations, evaluates the efficacy of interventions, and intelligently adjusts intervention plans. Administrators can monitor user data changes in real time via mobile and PC interfaces, significantly improving the efficiency of professional management. The system has undergone pilot testing in multiple elderly care institutions specializing in cognitive disorders, yielding positive market feedback.
On The Mend
Product Name: On The Mend
Product Introduction: On The Mend is a patient-friendly digital health platform transforming the experience and outcomes in physical rehabilitation. We enable personalised treatment plans, real-time progress tracking, and motivational tools to keep patients engaged throughout their rehab journey. Our platform streamlines care, empowering healthcare professionals to save time, collaborate seamlessly, and deliver top-quality outcomes.
Orange Family Technology (Tianjin) Co., Ltd.
Product Name: Digital Therapeutics for Inhalation Therapy - Intelligent Medication Instruction Robot
Product Introduction:
Both the GOLD and GINA guidelines emphasize that education and training on inhaler device technique cannot be overstated once an inhaled prescription is initiated. Studies have shown that educational interventions, including videos or online resources, can improve patients’ inhalation techniques. After comparing different training strategies, it has been found that inhalation training led by physicians, nurses, pharmacists, and physiotherapists better improves adherence and inhalation techniques in patients with chronic respiratory diseases. The “instruction + demonstration” approach yields more significant training outcomes. Patients should be asked to bring their own inhalers for face-to-face demonstrations of proper device usage, with regular reviews and assessments of their mastery of inhalation techniques to correct errors or omissions. During the “inhalation” step, smart sensors or electronic monitoring devices attached to the inhaler capture key actions such as coordination between actuation and inhalation, inspiratory flow rate, and duration. These objective measurements, combined with visual assessment, complete the evaluation and retraining of inhalation techniques. Intelligent medication-teaching robots, equipped with smart breath detectors and human-computer interaction systems, guide patients in learning the correct operation of inhaled medications. They provide timely, objective inhalation metrics with visual feedback, support simultaneous learning for multiple users, simplify healthcare professionals’ instructional workload, offer objective evidence for inhalation technique, and enhance the quality of patient education. Currently, intelligent medication-teaching robots for inhalation therapy are available with smart sensors compatible with pressurized metered-dose inhalers (pMDIs) and Ellipta devices. These sensors are installed on patients’ inhalation devices to capture critical inhalation maneuvers and analyze inhalation techniques.
Vivan Therapeutics
Product Name: TuMatch Software
Product Introduction:
Vivan Therapeutics has defined a new category of diagnostics and decision support to give people more effective treatment options when living with cancer. Vivan utilises a comprehensive, genomics-based drug screening technology developed at and in partnership with the Icahn School of medicine, Mount Sinai Medical Center (New York).
Our TuMatch software utilises AI/ML coupled with our proprietary mass in vivo drug screening data set to offer rapid personalised treatment recommendations.
We offer TuMatch for personalised colorectal and pancreatic cancer treatment recommendations and are interested in bringing TuMatch to the China market. We registered a China based company, Beijing Weiwan Medical Biotechnology Co Ltd, and are fundraising to support TuMatch market entry and laboratory expansion.
UK Global Technology Innovation Partner Alliance (GlobalTech IP)
Product Name: Go Global/Go China
Product Introduction:
“Go Global” Program: This six-month initiative integrates advanced market expansion strategies, ranging from customized global strategies and in-depth market analysis to the careful selection of market entry modes. Every step is grounded in thorough due diligence to ensure that market entry strategies are both robust and efficient. We provide full-lifecycle services covering market exploration, strategy formulation, and optimization upgrades. Backed by an expert team throughout the process, we accelerate enterprises’ global market penetration and sustainable growth through practical solutions and flexible strategic adjustments.
“Go China” links the innovation ecosystems of China and the rest of the world, focusing on implementing high-tech enterprises in the fields of life sciences, healthcare, sustainable development, and advanced manufacturing.
Haihu Health (Shandong) Group Co., Ltd.
Product Name: Digital Health End-to-End Construction Services
Product Introduction:
Leveraging the resource advantages of Haicheng Digital Medical Industrial Parks across multiple regions in China, and aligning with current trends in digital therapeutics and digital health, we provide compliant, regulated, end-to-end solutions for digital therapeutics and digital health, covering the entire process from concept to launch.
The services encompass five major categories: consulting, R&D, operations, regulatory registration, and clinical research. We provide DTx-CDMO solutions, a comprehensive incubation system, and an extended supply chain to support the sustained operation of products and projects.
Guangzhou Nanda Fit Medical Health Technology Co., Ltd.
Product Name: Tangdou AI Health Manager
Product Introduction:
Tangdou is an AI agent independently developed by Nanda Feite. Equipped with a deep learning engine and leveraging neural network technology, it continuously identifies users’ health needs. With an ever-expanding knowledge base that aggregates extensive and specialized medical expertise, Tangdou employs intelligent algorithms to filter and integrate data, performing real-time analysis of users’ weight, blood glucose levels, and lifestyle factors (including diet, physical activity, behavioral habits, and sleep patterns). It provides highly personalized intervention plans and precise health management recommendations.
Tangdou is not just an AI agent, but a health partner for individuals with obesity and diabetes; built on data and powered by intelligence, it connects users to every step of a healthy lifestyle. With technological support, medical-grade lifestyle intervention services become smarter, more efficient, thoughtful, and enjoyable.
Shenzhen Zhitou Medical Technology Development (Shanghai) Co., Ltd.
Product Name: SupBOOST
Product Introduction:
SupBOOST leverages patented deep learning technology to enhance lesion detectability in gadolinium-based contrast agent (GBCA)-enhanced brain T1-weighted images while maintaining diagnostic accuracy. In other words, SupBOOST enhances the imaging efficacy of gadolinium agents without actually increasing the GBCA dose, thereby achieving superior image quality and supporting improved clinical decision-making. Contrast Enhancement Percentage (CEP) data indicate that the contrast dose information content in SupBOOST images is approximately twice that of standard-dose images (with an average CEP of around 180%). The innovative features of this product include: 1. Patented Deep Learning Algorithm: SupBOOST employs a unique deep learning algorithm trained to predict 100% dose T1+C images from pre-contrast T1 and 10% dose T1+C images. During testing, it can also generate further dose-enhanced images by inputting pre-contrast T1 and 100% dose T1+C images, delivering exceptional image quality. 2. Enhanced Contrast Visualization: The contrast agent information in the enhanced images exceeds that of a 100% dose, ensuring high-quality visualization and supporting precise diagnosis. 3. Vascular Signal Suppression: This patented deep learning algorithm can selectively suppress certain vascular signals in enhanced images, further improving diagnostic clarity. The product has recently received FDA clearance. Currently, DeepWise Medical is extending the application of this technology to other anatomical regions, such as the breast and spine, through dose simulation methods, thereby broadening its clinical utility and planning future expansion to additional imaging modalities like CT.
Hainan Ecological Software Park
Hainan Ecological Software Park is jointly developed by China Electronics Corporation and the People's Government of Hainan Province under the model of "government support and market-oriented operation." With a total planned area of 18 square kilometers, the park is the first in Hainan Province to implement the "one park, one policy" framework. It is one of the twelve national digital service export bases, a key carrier for Hainan's Free Trade Port construction, and the Hainan Provincial Digital Medical Health Innovation Base. The park has been successively recognized as a National-Level Science and Technology Business Incubator (the first of its kind in Hainan Province), a National Demonstration Base for New Industrialization, and one of the first batches of Strategic Emerging Industry Clusters.
Shuimu Jinsheng
Beijing Shuimu Jinsheng Medical Technology Service Co., Ltd. is a professional incubation platform centered on medical device CDMO (Contract Development and Manufacturing Organization). It has meticulously built the "Zhongguancun Shuimu Medical Seven-Star Incubator" and has been accredited as the sole benchmark incubator for leading hard-tech medical devices in Beijing. The company provides entrepreneurial consulting, investment and financing services, R&D collaboration, project application support, professional technical matchmaking, and customized incubation services tailored to the needs of enterprises at different stages.Leveraging the Medical Device Registrant System, the company has established a compliant, professional R&D and manufacturing service platform. It boasts industry-leading project experience, a robust execution team, and extensive industry resources. The facility includes over 9,000 square meters of GMP-compliant R&D and production workshops, featuring Class 10,000 and Class 100,000 high-standard cleanrooms and production areas, as well as a sterile validation and testing center. Additionally, the company operates a 3,500-square-meter R&D laboratory center equipped with specialized laboratories for usability, reliability, physicochemical analysis, biochemistry, immunology, PCR, and microbiology.
ALSOLIFE (Beijing Asou Aba Technology Co., Ltd.)
Beijing Asuo Aba Technology Co., Ltd. is a leading digital healthcare service provider in China specializing in pediatric mental health and neurodevelopmental disorders. Its team comprises professionals from top-tier institutions and technology companies such as Peking Union Medical College, IBM, and Nortel Networks, featuring world-class expert teams in medicine, psychology, and special education, as well as development teams with national-level software platform development experience and artificial intelligence algorithm specialists. Leveraging comprehensive digital capabilities across both online and offline operations, ALSOLIF maximizes the substitution of manual labor with AI and delivers medical-grade digital rehabilitation services for children with autism spectrum disorder and other neurodevelopmental disorders through rigorous, evidence-based clinical processes.
Haihu Health
Haicheng Digital Medical Industrial Park, under Haihu Health, is a comprehensive industrial base dedicated to providing end-to-end digital healthcare infrastructure services for internet healthcare enterprises. Leveraging local government investment promotion platforms, it has established digital medical industrial parks in Qingdao, Yinchuan, Tianjin, Changsha, Haikou, and other cities. The park has successfully incubated hundreds of digital healthcare companies and boasts a team with extensive experience and specialized expertise in building and operating digital healthcare platforms.By leveraging its robust resources, the park provides one-stop comprehensive support services for internet healthcare industries, including office space, affiliated physical medical institutions, assistance in applying for internet hospital licenses, construction of internet hospital system platforms, operational management, pharmaceutical warehousing and supply chain solutions, classified protection of cybersecurity (MLPS), industrial synergy, investment and financing, health management, medical payment solutions, medical and health services, AI intelligence, commercial insurance, and enterprise incubation. This holistic approach fully empowers medical institutions and enterprises.
Nanda Feite Medical Health
Nanda Feite was established in April 2014 as the first company in China to specialize in medical weight management and diabetes management. It is committed to building a leading digital healthcare platform for chronic disease management in China by leveraging medical artificial intelligence and new quality productive forces. With the support of the professorial team from Southern Medical University, the Obesity and Weight Management Professional Committee of the Guangdong Association of Integrative Traditional Chinese and Western Medicine, and the Endocrine and Metabolic Disease Prevention and Control Professional Committee of the Guangdong Preventive Medicine Association, and by integrating cutting-edge research literature and clinical guidelines, the company has facilitated the implementation of intervention and management programs for overweight and obese populations in regions such as Guangdong Province, Jiangsu Province, and Shanghai. These efforts have involved more than 40 Grade-A tertiary hospitals, JD Health, and Meinian Onehealth. To date, the company has helped over 30,000 patients achieve weight and fat loss, stabilize blood glucose levels, and improve chronic disease indicators. Nanda Feite has been consecutively recognized as one of the Top 50 Enterprises in the Guangdong-Hong Kong-Macao Greater Bay Area for four years, has received High-Tech Enterprise certification twice, was honored as one of the Top 20 AIGC Healthcare Companies in the 2023 China Innovation and Entrepreneurship Competition, and was selected as an outstanding case study in weight management by the National Center for Chronic and Noncommunicable Disease Control and Prevention of the Chinese Center for Disease Control and Prevention in 2024.
Sanya Yazhou Bay Science and Technology City
Yazhou Bay Science and Technology City in Sanya is located in the western part of Sanya, Hainan Province, with a total planned area of approximately 69.3 square kilometers. In accordance with the overall requirements of the Master Plan for the Hainan Free Trade Port, it is focused on building a science and technology-oriented high-tech development zone led by deep-sea technology and the Nanfan seed breeding industry, with coordinated development of life sciences, the digital economy, and other sectors. It is one of the key parks in the Hainan Free Trade Port whose construction is being prioritized by Sanya City to implement General Secretary Xi Jinping’s important speech of April 13 and the spirit of Central Document No. 12, in line with the decisions and deployments of the Hainan Provincial Party Committee and Provincial People’s Government.
Yazhou Bay Science and Technology City is structured around the framework of “global vision, international standards, Sanya characteristics, and high-level positioning,” committed to building a pioneering new science and technology city that integrates land and sea development, embraces openness and innovation, fosters industrial prosperity, promotes cultural confidence, and prioritizes green energy efficiency.
12mm Health Tech
Founded on October 23, 2023, in Haikou High-Tech Industrial Park, the company is an artificial intelligence enterprise dedicated to children’s eye health. Its product portfolio focuses on myopia prevention and control systems, establishing personalized, dynamic intervention plans centered around family units. We are evolving into an integrated solution provider that combines hardware development, software development, AI algorithms, and medical services, addressing the essential needs of population-wide vision health management. Our mission is to establish a sustainable digital healthcare system for myopia prevention and control in the field of optometry, safeguarding the visual health of Chinese children and adolescents and reducing the incidence of myopia. Our vision is to protect the vision health of 250 million children and adolescents in China, thereby contributing to the strength of our nation.
Shuimu Jingchuang
Beijing Shuimu Jingchuang Pharmaceutical Technology Co., Ltd. is a contract research organization (CRO) dedicated to providing professional clinical research technical services to medical device enterprises. It primarily offers specialized technical services and one-stop solutions for medical device (including in vitro diagnostic reagents) companies, covering medical device clinical trials, medical writing, global registration, and GMP consulting. Its areas of expertise include proton and heavy ion therapy, surgical robots, IVD, medical aesthetics, and digital therapeutics. The company focuses mainly on innovative, China-produced Class III medical devices, encompassing nearly all categories, including active, passive, and IVD products. Projects are delivered on time with high quality; operational efficiency is high, leading to rapid regulatory approval; and the pass rate for inspections by the National Medical Products Administration (NMPA) and provincial medical products administrations is 100%.
Conference Name:2024 Digital Therapeutics Conference
Conference Date:2024August 30–31
Conference Venue:Hainan · Haikou Luneng Hilton Hotel
Supporting Organizations:Youth Health Economics Committee of the Chinese Society of Health Economics, Health Industry Branch of the Chinese Society of Health Economics, Digital Therapeutics Professional Committee of the China Association for Medical Device Industry, Healthcare and Health Industry Branch of the China Information Association, ChinaPromotion Association for the Industrialization of Science and TechnologyDigital Health Professional Committee, Maternal and Child Health Big Data and Artificial Intelligence Professional Committee of the China Association for Maternal and Child Health, Beijing Society for Human Injury Repair Research, Chinese Society of Biopharmaceutical Technology,Hainan Provincial Association of Non-Public Medical Institutions
(Free Registration)
